New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evide...

por Kaul, Upendra, Parmar, Deven, Manjunath, K., Shah, Mitesh, Parmar, Krupi, Patil, Kishor P., Jaiswal, Ashok
Publicado 2019